
Sign up to save your podcasts
Or


Mark McKenna, chairman and CEO at Mirador Therapeutics, speaks with Venrock partner Nimish Shah to discuss his most recent role at Prometheus Biosciences and the beginning of his new company, Mirador. McKenna shares a behind-the-scenes look into leading Prometheus during its acquisition by Merck, why he started Mirador Therapeutics, advice for other CEOs, what he values in a team and more.
By Venrock, a venture capital firm4.8
6262 ratings
Mark McKenna, chairman and CEO at Mirador Therapeutics, speaks with Venrock partner Nimish Shah to discuss his most recent role at Prometheus Biosciences and the beginning of his new company, Mirador. McKenna shares a behind-the-scenes look into leading Prometheus during its acquisition by Merck, why he started Mirador Therapeutics, advice for other CEOs, what he values in a team and more.

1,290 Listeners

2,671 Listeners

2,444 Listeners

1,100 Listeners

341 Listeners

324 Listeners

396 Listeners

5,522 Listeners

9,902 Listeners

34 Listeners

506 Listeners

19 Listeners

265 Listeners

521 Listeners

1,356 Listeners